Biomarkers and Personalized Medicine
12.3K views | +1 today
Follow
Biomarkers and Personalized Medicine
Sharing relevant articles on advancements in personalized medicine
Curated by Brian Shields
Your new post is loading...
Your new post is loading...
Scooped by Brian Shields
Scoop.it!

Low Mmp 9 and VEGF levels predict good oncologic outcome in mid and low rectal cancer patients with neoadjuvant chemoradiation

Low Mmp 9 and VEGF levels predict good oncologic outcome in mid and low rectal cancer patients with neoadjuvant chemoradiation - up-to-the-minute news and headlines.
more...
No comment yet.
Scooped by Brian Shields
Scoop.it!

Circadian Technologies starts clinical trial for VEGF-C cancer antibody

Circadian Technologies starts clinical trial for VEGF-C cancer antibody | Biomarkers and Personalized Medicine | Scoop.it
Circadian Technologies (ASX:CIR, OTCQX:CKDXY) has commenced the first Phase 1 clinical trial of its fully human monoclonal antibody against VEGF-C, VGX-100, at a leading US-based cancer treatment centre.
more...
No comment yet.
Scooped by Brian Shields
Scoop.it!

Immunohistochemical Study of VEGF and Matrilysin (MMP-7) in T1 ...

Immunohistochemical Study of VEGF and Matrilysin (MMP-7) in T1 Adenocarcinoma of the Colon and Rectum to Predict Lymph Node Metastases or Distant Metastases. January 11th, 2012. Chien-Yuh Yeh, Jy-Ming Chiang, Pao-Shiu Hsieh, ...
more...
No comment yet.